St. Helena, CA, United States of America

Martin A Murphy

This inventor holds 1 USPTO granted patent. Top assignee: Propharmacon Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin A Murphy. Retrieved from https://idiyas.com/inventor/martin-a-murphy-nop4gue8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Unveiling the Inventive Mind of Martin A Murphy

Introduction: Martin A Murphy, a prolific inventor based in St. Helena, CA (US), is making waves in the pharmaceutical industry with his groundbreaking patent on Topoisomerase inhibitors. His remarkable contributions are transforming the landscape of treating cell-proliferative disorders, particularly in the realm of anticancer therapies.

Latest Patents: Martin A Murphy has one pivotal patent under his belt, focusing on compounds that effectively inhibit topoisomerase I and/or topoisomerase II. These compounds demonstrate significant potential in combatting cell-proliferative disorders, including their efficacy against multi-drug resistant cancers.

Career Highlights: Currently affiliated with Propharmacon Inc., Martin A Murphy's expertise and innovative spirit shine through his work. His dedication to developing novel compounds underscores his commitment to advancing medical treatments and improving patient outcomes.

Collaborations: In his professional journey, Martin A Murphy has collaborated with esteemed colleagues such as John Robert Schullek and John S Ward. Together, they form a dynamic team driving forward cutting-edge research and development efforts in the field of pharmaceuticals.

Conclusion: In conclusion, Martin A Murphy stands as a visionary inventor whose ingenuity is reshaping the landscape of medical treatments. With a keen focus on addressing cell-proliferative disorders, particularly in the context of anticancer therapies, Martin's contributions are paving the way for innovative solutions that have the potential to impact countless lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…